Ropivacaine 0.2% 400 MG/200 ML 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FX3V1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,137
Award facts
- Contract value 100% obligated
- $1,136.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,136.89 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 mL in 200 mL units). This non-set-aside, firm fixed-price delivery order was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, routinely fulfills such delivery orders for the DLA Medical Supply Chain across a comprehensive range of therapeutic domains. Ropivacaine is a local anesthetic used in clinical and surgical settings, aligning with the company's established portfolio of pharmaceutical deliveries to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside delivery orders demonstrates its capability to meet federal procurement requirements and maintain reliable supply chains for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FX3V1?
SPE2DR26FX3V1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FX3V1 worth?
The government has obligated $1,137 on SPE2DR26FX3V1.
Is contract SPE2DR26FX3V1 an order under another contract?
Yes. SPE2DR26FX3V1 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX3V1 competed?
The extent of competition for SPE2DR26FX3V1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award